107 related articles for article (PubMed ID: 22223435)
1. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
[TBL] [Abstract][Full Text] [Related]
2. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
[TBL] [Abstract][Full Text] [Related]
3. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
4. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
5. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
[TBL] [Abstract][Full Text] [Related]
6. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer.
McMillen E; Ye F; Li G; Wu Y; Yin G; Liu W
Exp Lung Res; 2010 Nov; 36(9):531-7. PubMed ID: 20939760
[TBL] [Abstract][Full Text] [Related]
8. Impact of EGFR mutation analysis in non-small cell lung cancer.
Yamamoto H; Toyooka S; Mitsudomi T
Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
[TBL] [Abstract][Full Text] [Related]
9. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
[TBL] [Abstract][Full Text] [Related]
10. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
Pesek M; Benesova L; Belsanova B; Mukensnabl P; Bruha F; Minarik M
Anticancer Res; 2009 Jul; 29(7):2767-73. PubMed ID: 19596959
[TBL] [Abstract][Full Text] [Related]
11. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Jänne PA; Johnson BE
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4416s-4420s. PubMed ID: 16857820
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
Johnson BE; Jänne PA
Cancer Res; 2005 Sep; 65(17):7525-9. PubMed ID: 16140912
[TBL] [Abstract][Full Text] [Related]
13. Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients.
He Y; Li S; Ren S; Cai W; Li X; Zhao C; Li J; Chen X; Gao G; Li W; Zhou F; Zhou C
Lung Cancer; 2013 Aug; 81(2):162-6. PubMed ID: 23726438
[TBL] [Abstract][Full Text] [Related]
14. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas.
Pham D; Kris MG; Riely GJ; Sarkaria IS; McDonough T; Chuai S; Venkatraman ES; Miller VA; Ladanyi M; Pao W; Wilson RK; Singh B; Rusch VW
J Clin Oncol; 2006 Apr; 24(11):1700-4. PubMed ID: 16505411
[TBL] [Abstract][Full Text] [Related]
15. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis.
Wu Y; Liu H; Shi X; Song Y
Lung Cancer; 2015 Jun; 88(3):246-53. PubMed ID: 25837799
[TBL] [Abstract][Full Text] [Related]
16. A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.
Hong S; Fang W; Hu Z; Zhou T; Yan Y; Qin T; Tang Y; Ma Y; Zhao Y; Xue C; Huang Y; Zhao H; Zhang L
Sci Rep; 2014 Dec; 4():7268. PubMed ID: 25434695
[TBL] [Abstract][Full Text] [Related]
17. Proportion and clinical features of never-smokers with non-small cell lung cancer.
Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.
Chiang HC; Lee H; Chao HR; Chiou YH; Tsou TC
Cancer Epidemiol; 2013 Oct; 37(5):653-9. PubMed ID: 23752126
[TBL] [Abstract][Full Text] [Related]
19. [Is lung cancer in women different?].
Ben Aissa A; Mach N
Rev Med Suisse; 2012 May; 8(342):1108-11. PubMed ID: 22734179
[TBL] [Abstract][Full Text] [Related]
20. Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetite.
Maruyama K; Takeyama H; Mori T; Ohshima K; Ogura S; Mochizuki T; Matsunaga T
Biosens Bioelectron; 2007 Apr; 22(9-10):2282-8. PubMed ID: 17187977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]